Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine and Omeprazole in New Onset Type 1 Diabetes
NCT01762644Phase 3Withdrawn
- Sponsor
- Perle Bioscience
- Start
- Aug 2015
- Primary completion
- May 2016
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 3 trial of cyclosporine, omeprazole in type 1 diabetes mellitus (T1D), sponsored by Perle Bioscience. Planned start Aug 2015; status: withdrawn.
02
Drugs
cyclosporineomeprazole
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01762644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01762644.